Myositis: all 246 studies
Page 2 of 3. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Optimizing Treatment on Idiopathic Inflammatory MyopathiesRecruitingNCT03092180
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
- Adult and Juvenile MyositisRecruitingNCT00017914
- Myositis Interstitial Lung Disease Nintedanib TrialCompletedNCT05799755Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body MyositisCompletedNCT05721573Phase 2/3Results posted
- A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)CompletedNCT05669014Phase 2Results posted
- Study of M5049 in DM and PM Participants (NEPTUNIA)TerminatedNCT05650567Phase 2Results posted
- Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.CompletedNCT04628936Phase 2Results posted
- Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension TrialTerminatedNCT04049097Phase 3Results posted
- A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or DermatomyositisCompletedNCT04033926Phase 2Results posted
- Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal ConditionsTerminatedNCT03912428Phase 1Results posted
- Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisCompletedNCT03267277Phase 2/3Results posted
- Abatacept for the Treatment of Myositis-associated Interstitial Lung DiseaseCompletedNCT03215927Phase 2Results posted
- Evaluation of Moderate to Severe Influenza Outcomes in ChildrenCompletedNCT02979626Results posted
- Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyCompletedNCT02971683Phase 3Results posted
- Study of Arimoclomol in Inclusion Body Myositis (IBM)CompletedNCT02753530Phase 2Results posted
- An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203CompletedNCT02573467Phase 3Results posted
- Belimumab in Idiopathic Inflammatory MyositisCompletedNCT02347891Phase 2/3Results posted
- Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisCompletedNCT02250443Phase 2/3Results posted
- Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM PatientsCompletedNCT01925209Phase 2/3Results posted
- Ultrasound in Muscle BiopsyCompletedNCT01790178Not applicableResults posted
- Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle SymptomsCompletedNCT01032993Phase 2/3Results posted
- A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or MyositisCompletedNCT00979654Phase 2Results posted
- The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory MarkersCompletedNCT00805870Phase 2Results posted
- Arimoclomol in Sporadic Inclusion Body MyositisCompletedNCT00769860Phase 2/3Results posted
- Stem Cell Transplantation in Idiopathic Inflammatory Myopathy DiseasesTerminatedNCT00278564Phase 1Results posted
- Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)CompletedNCT00106184Phase 2Results posted
- Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory MyopathiesWithdrawnNCT07564271
- A Study of BEN301 Injection in theTreatment of Autoimmune DiseasesSuspendedNCT07527936Early Phase 1
- UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune DiseasesWithdrawnNCT07410377Early Phase 1
- Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07361094Phase 1
- the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune DiseasesActive, not recruitingNCT07339540Early Phase 1
- Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
- Virtual Reality and Robotics in Inflammatory Myopathy RehabilitationCompletedNCT06968819Not applicable
- Multispectral Optoacustic Imaging in Patients With MyositisCompletedNCT06966739
- A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune DiseasesWithdrawnNCT06913608Phase 1
- A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT06866080Early Phase 1
- Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive, not recruitingNCT06665256Phase 2
- Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune DiseasesSuspendedNCT06549296Early Phase 1
- A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory MyopathiesTerminatedNCT06524687Phase 1
- A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)Active, not recruitingNCT06508021Phase 2/3
- IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory MyopathyTerminatedNCT06462144Early Phase 1
- Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-BeingCompletedNCT06300983Not applicable
- A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With DermatomyositisActive, not recruitingNCT06284954Phase 2
- A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
- Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic OssificationsCompletedNCT06251349
- CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101Active, not recruitingNCT06152172Phase 1
- Effect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained RowersCompletedNCT06133751Phase 4
- Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune DiseasesActive, not recruitingNCT06029335
- The Effect of Supplementation of Vitamin D3 on Inflammation Induced by 100 km Running, Iron Metabolism and ErythropoiesisCompletedNCT05880030Not applicable
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 4
- A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Active, not recruitingNCT05869955Phase 1
- Add-on Intravenous Immunoglobulins in Early MyositisActive, not recruitingNCT05832034Phase 2/3
- Inflammatory and Degenerative Muscle DiseaseStatus unknownNCT05738590
- Magnetic Resonance Imaging and Ultrasonography in Evaluation of Muscle DiseasesStatus unknownNCT05692349
- Evaluation of Peripheral Neutrophils in Antisynthetase SyndromeCompletedNCT05691725
- Rheumatoid Arthritis and Myositis CohortWithdrawnNCT05627089
- A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.CompletedNCT05523167Phase 2/3
- Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory MyopathiesStatus unknownNCT05400889Phase 2
- A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesActive, not recruitingNCT05379634Phase 2
- Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung DiseaseTerminatedNCT05335278Not applicable
- Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular DisordersCompletedNCT05200702Not applicable
- Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular DisordersCompletedNCT05199246Not applicable
- Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg CellsStatus unknownNCT05129410Phase 4
- Cell Therapy for IBM by Muscle Injection of ADSVFStatus unknownNCT05032131Phase 1
- Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory MyopatiesCompletedNCT05027152Not applicable
- Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational StudyStatus unknownNCT04941079
- Evaluation of Interstitial Lung Disease Severity in Patients With Antisynthetase Syndrome According to Specific Autoantibodies ProfileStatus unknownNCT04924465
- Musculoskeletal Nociceptive Pain in Participants With Neuromuscular DisordersCompletedNCT04907162
- COVID-19 Vaccination in Rheumatic Disease PatientsTerminatedNCT04839315Early Phase 1
- Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvationStatus unknownNCT04687111Phase 2
- PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSActive, not recruitingNCT04664465
- A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients with (IBM)CompletedNCT04659031Phase 1
- Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)CompletedNCT04637672
- Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesStatus unknownNCT04530461
- High-intensity Strength Training in MyositisCompletedNCT04486261Not applicable
- Safety and Tolerability of Phenylbutyrate in Inclusion Body MyositisCompletedNCT04421677Phase 1
- Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular InvolvementStatus unknownNCT04367350
- Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid PopulationsTerminatedNCT04309227Not applicable
- Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory MyopathyStatus unknownNCT04237987Phase 2
- JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIMCompletedNCT04208464Phase 2
- Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory MyopathyStatus unknownNCT04062019Phase 2
- Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic AcidStatus unknownNCT04034199Phase 3
- Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care UnitStatus unknownNCT04022655
- Smartphone Mindfulness Meditation for Patients With Rheumatic DiseasesTerminatedNCT03937856Not applicable
- Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory MyopathiesCompletedNCT03918356Not applicable
- Elastography in Patients With Idiopathic Inflammatory MyopathiesStatus unknownNCT03897803
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Comparison Between CT and MRI in Preoperative Evaluation of Neurogenic Myositis Ossificans or Neurogenic Para-osteo-arthritisCompletedNCT03832556Not applicable
- Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular DiseasesCompletedNCT03786913
- Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
- Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained MenCompletedNCT03760757Not applicable
- Cell Surface Marker Expression in Autoimmune DiseasesCompletedNCT03757065
- Influence of Aerobic Training and Weight Loss on Skeletal Muscle Inflammatory Markers and Muscle Protein Balance in Older AdultsStatus unknownNCT03743675Not applicable
- Feasibility of a Blended Therapy ApproachCompletedNCT03713151Not applicable
- Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body MyositisWithdrawnNCT03710941Phase 2
- Establishing Muscle Impedance Parameters With Electrical Impedance MyographyCompletedNCT03633318
- Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReActionCompletedNCT03492242
- Study of Pioglitazone in Sporadic Inclusion Body MyositisCompletedNCT03440034Phase 1